Content Group | Rovereto s/S Plant

Content Group | Rovereto s/S Plant

COC Farmaceutici srl: commercial and administrative headquarters; manufacturing facility

About the plant

Content Group is an all-Italian pharmaceutical CDMO composed of COC Farmaceutici and Tubilux Pharma. The Group develops and manufactures liquid, gel, cream and lyophilized pharmaceuticals, medical devices and cosmetics for human and veterinary use. With decades of experience in ophthalmic and respiratory sectors, Content Group is among Europe’s leading players, serving partners worldwide with full CDMO services, innovation and quality as core values.

COC Farmaceutici | Rovereto s/Secchia (MO)

The Rovereto site is the commercial and administrative headquarters of COC Farmaceutici as well as a manufacturing facility. It specializes in the production of liquid, cream and gel formulations for medical devices and cosmetics, manufactured under both sterile and non-sterile conditions.

Certifications:
ISO 22716 – Manufacturing of Cosmetics
ISO 13485 – Manufacturing of Medical Devices
CQY Certiquality | TÜV Rheinland | IMQ

2024 Production Volumes:
• 17.5 million bottles
• 15.5 million strips of 5 plastic ampoules
• 600,000 plastic tubes with silicone applicator

Main Sectors:
Eye care | Nasal care | Respiratory care | Dermatological | Food supplements | Diagnostic | Hair care | Skin care | Spot-on for pets

Primary Packaging Formats:
Preservative-free multidose bottles | Multidose bottles | Strips of 5 plastic ampoules | Eye sprays | Nasal sprays | Plastic tubes with silicone applicator | Bottles with pump dispenser

---

Certifications

• ISO

---

Activity

• Oral liquids and semisolids, Sterile forms (ophtalmic, nasal, otic), Topical, mucosal and transdermal, Ampoules, Oral solutions, Fill&Finish, Bottles, Dropper bottles, Ophtalmic dispensers, Tubes, Sprays, Semisolid forms, FDF / DRUG PRODUCTS, COSMETICS, SERVICES, Skin products, Skin care, Other skin care products, Cream / paste manufacturing

---

Features

• Uses: Commercial (Phase IV), Human
• Toxicity (OEB classification): N/A
• DEA: N/A
• BSL: N/A
• Therapeutic areas: N/A
• Markets: EMA (EU), MHRA (UK), EDE (UAE), SFDA (Saudi Arabia)

---

Batch Size / Reactor

• Medium, Large

---

Services

• Regulatory services, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging, Logistics, Preformulation studies, R&D, Formulation / Galenic design, Process development, Process optimization, Process validation, Stability studies design, Stability studies execution, ICH Stability studies, Comparability studies, Tech transfer, Pilot plant, Engineering batches, Scale-up, Pilot batches, Batch records, Analytical methods development, Analytical methods validation, Analytical methods transfer, QP in house, Batch certification / release, Primary packaging, Secondary packaging, Labeling, Serialization, Storage, CMC regulatory support

---